Rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria treated with anti-tumor 1,4-anthracenediones

Anti-Cancer Drugs

Volumn 16, Issue 9, 2005, Pages 953-967

  Wang, Yang ^a   Perchellet, Elisabeth M ^a   Ward, Mary M ^a   Lou, Kaiyan ^a   Hua, Duy H ^a   Perchellet, Jean Pierre H ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Anti tumor 1,4 anthracenediones; HL 60 cell; Isolated mitochondria; Mitochondrial membrane potential

Indexed keywords

1,4 ANTHRAQUINONE DERIVATIVE; ALAMETHICIN; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; BONGKREKIC ACID; CALCIUM CHLORIDE; CALCIUM ION; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CASPASE 2; CASPASE 2 INHIBITOR; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE INHIBITOR; CYCLOSPORIN A; CYTOCHROME C; DAUNORUBICIN; DECYLUBIQUINONE; GRAMICIDIN A; MITOXANTRONE; RHODAMINE 123; RUTHENIUM RED; STAUROSPORINE; UBIQUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL FREE SYSTEM; CELL STRAIN HL 60; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE DEPOLARIZATION; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; WILD TYPE;

ALAMETHICIN; ANIMALS; ANTHRAQUINONES; BONGKREKIC ACID; CALCIUM CHLORIDE; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CYCLOSPORINE; CYSTEINE PROTEINASE INHIBITORS; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; FEMALE; GRAMICIDIN; HL-60 CELLS; HUMANS; INTRACELLULAR MEMBRANES; ION CHANNELS; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOXANTRONE; P-GLYCOPROTEIN; RUTHENIUM RED; STAUROSPORINE; UBIQUINONE;

EID: 26244452602     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cad.0000180123.24031.5a     Document Type: Article

References (76)

1. Monks TJ, Hanzlik RP, Cohen GM, Ross D, Graham DG. Quinone chemistry and toxicity. Toxicol Appl Pharmacol 1992; 112:2-16.
2. Debatin KM. Activation of apoptosis pathways by anticancer treatment. Toxicol Lett 2000; 112/113:41-48.
3. Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000; 256:42-49.
4. Perchellet EM, Magill MJ, Huang X, Dalke DM, Hua DH, Perchellet JP. 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro. Anticancer Drugs 2000; 11:339-352.
5. Wu M, Wang B, Perchellet EM, Sperfslage BJ, Stephany HA, Hua DH, et al. Synthetic 1,4-anthracenediones, which block nucleoside transport and induce DNA fragmentation, retain their cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines. Anticancer Drugs 2001; 12:807-819.
6. Perchellet EM, Wang Y, Weber RL, Sperfslage BJ, Lou K, Grassland J, et al. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling. Biochem Pharmacol 2004; 67:523-537.
7. Hua DH, Lou K, Havens J, Perchellet EM, Wang Y, Perchellet JP, et al. Synthesis and in vitro anti-tumor activity of substituted anthracene-1,4-diones. Tetrahedron 2004; 60:10155-10163.
8. Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME, et al. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 1998; 273:33942-33948.
9. Susin SA, Larochette N, Geuskens M, Kroemer G. Purification of mitochondria for apoptosis assays. Methods Enzymol 2000; 322: 205-208.
10. Custodio JBA, Cardoso CMP, Almeida LM. Thiol protecting agents and antioxidants inhibit the mitochondrial permeability transition promoted by etoposide: implications in the prevention of etoposide-induced apoptosis. Chem-Biol Interact 2002; 140:169-184.
11. Blattner JR, He L, Lemasters JJ. Screening assays for the mitochondrial permeability transition using a fluorescence multiwell plate reader. Anal Biochem 2001; 295:220-226.
12. Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 1991; 30:4480-4486.
13. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′- tetrachloro-1,1′,3, 3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993; 197:40-45.
14. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 1997; 411:77-82.
15. Emaus RK, Grunwald R, Lemasters JJ. Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties. Biochim Biophys Acta 1986; 850:436-448.
16. Scaduto RC Jr, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 1999; 76:469-477.
17. Das MK, Basu A, Balaram P. Effects of membrane channel-forming polypeptides on mitochondrial oxidative phosphorylation. A comparison of alamethicin, gramicidin A, melittin and tetraacetyl melittin. Biochem Int 1985; 11:357-363.
18. Walter L, Miyoshi H, Leverve X, Bernardi P, Fontaine E. Regulation of the mitochondrial permeability transition pore by ubiquinone analogs. A progress report. Free Rad Res 2002; 36:405-412.
19. Fontaine E, Ichas F, Bernardi P. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J Biol Chem 1998; 273:25734-25740.
20. 2+ signaling and apoptosis. J Bioenerg Biomembr 2000; 32:35-46.
21. Yu S-W, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297:259-263.
22. Chiarugi A, Moskowitz MA. PARP-1: a perpetrator of apoptotic cell death? Science 2002; 297:200-201.
23. + depletion and mitochondrial permeability transition. J Biol Chem 2004; 279:18895-18902.
24. Kang Y-H, Yi M-J, Kim M-J, Park M-T, Bae S, Kang C-M, et al. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res 2004; 64:8960-8967.
25. Decaudin D, Marzo I, Brenner C, Kroemer G. Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy [Review]. Int J Oncol 1998; 12:141-152.
26. Grad JM, Cepero E, Boise LH. Mitochondria as targets for established and novel anti-cancer agents. Drug Resist Updates 2001; 4:85-91.
27. Joseph B, Marchetti P, Formstecher P, Kroemer G, Lewensohn R, Zhivotovsky B. Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment. Oncogene 2002; 21:65-77.
28. Solary E, Bettaieb A, Dubrez-Daloz L, Corcos L. Mitochondria as a target for inducing death of malignant hematopoietic cells. Leuk Lymph 2003; 44:563-574.
29. Sun S-Y, Hail N Jr, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 2004; 96:662-672.
30. Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Distinct pathways for stimulation of cytochrome c release. J Biol Chem 2000; 275:32438-32443.
31. André N, Braguer D, Brasseur G, Gonçalves A, Lemesle-Meunier D, Guise S, et al. Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells. Cancer Res 2000; 60:5349-5353.
32. Souid A-K, Tacka KA, Galvan KA, Penefsky HS. Immediate effects of anticancer drugs on mitochondrial oxygen consumption. Biochem Pharmacol 2003; 66:977-987.
33. Huigsloot M, Tijdens IB, Mulder GJ, van de Water B. Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells. J Biol Chem 2002; 277:35869-35879.
34. Rebbaa A, Chou PM, Emran M, Mirkin BL. Doxorubicin-induced apoptosis in caspase-8-deficient neuroblastoma cells is mediated through direct action on mitochondria. Cancer Chemother Pharmacol 2001; 48: 423-428.
35. Tong X, Lin S, Fujii M, Hou D-X. Echinocystic acid induces apoptosis in HL-60 cells through mitochondria-mediated death pathway. Cancer Lett 2004; 212:21-32.
36. Zhang S, Ong C-N, Shen H-M. Involvement of proapoptotic Bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis. Cancer Lett 2004; 211:175-188.
37. Kim JS, Lee JM, Chwae Y-J, Kim YH, Lee JH, Kim K, et al. Cisplatin-induced apoptosis in Hep3B cells: mitochondria-dependent and -independent pathways. Biochem Pharmacol 2004; 67:1459-1468.
38. Ahn HJ, Kim YS, Kim J-U, Han SM, Shin JW, Yang HO. Mechanism of taxol-induced apoptosis in human SKOV3 ovarian carcinoma cells. J Cell Biochem 2004; 91:1043-1052.
39. Shibata M-A, Ito Y, Morimoto J, Otsuki Y. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism. Carcinogenesis 2004; 25:1887-1898.
40. Sen N, Das BB, Ganguly A, Mukherjee T, Tripathi G, Bandyopadhyay S, et al. Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani. Cell Death Differ 2004; 11:924-936.
41. Piret J-P, Arnould T, Fuks B, Chatelain P, Remade J, Michiels C. Mitochondria permeability transition-dependent tert-butyl hydroperoxide-induced apoptosis in hepatoma HepG2 cells. Biochem Pharmacol 2004; 67:611-620.
42. Schempp CM, Kirkin V, Simon-Haarhaus B, Kersten A, Kiss J, Termeer CC, et al. Inhibition of tumor cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 2002; 21:1242-1250.
43. Marchetti P, Zamzami N, Joseph B, Schraen-Maschke S, Méreau- Richard C, Costantini P, et al. The novel retinoid 6-[3-(1-adamantyl)-4- hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus. Cancer Res 1999; 59:6257-6266.
44. Zhang XD, Gillespie SK, Hersey P. Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways. Mol Cancer Ther 2004; 3:187-197.
45. Ricci J-E, Waterhouse N, Green DR. Mitochondrial functions during cell death, a complex (I-V) dilemma. Cell Death Differ 2003; 10:488-492.
46. Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2001; 2:67-71.
47. Shimizu S, Marita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399:483-487.
48. Donovan M, Cotter TG. Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim Biophys Acta 2004; 1644:133-147.
49. Chelli B, Lena A, Vanacore R, Da Pozzo E, Costa B, Rossi L, et al. Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Biochem Pharmacol 2004; 68:125-134.
50. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 1999; 79:1127-1155.
51. m) in apoptosis; an update. Apoptosis 2003; 8:115-128.
52. Pervaiz S, Seyed MA, Hirpara JL, Clément M-V, Loh KW. Purified photoproducts of merocyanine 540 trigger cytochrome c release and caspase 8-dependent apoptosis in human leukemia and melanoma cells. Blood 1999; 93:4096-4108.
53. Facompré M, Wattez N, Kluza J, Lansiaux A, Bailly C. Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide. Mol Cell Biol Res Commun 2000; 4:37-42.
54. Chen LB. Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 1988; 4:155-181.
55. Ravagnan L, Roumier T, Kroemer G. Mitochondria, the killer organelles and their weapons. J Cell Physiol 2002; 192:131-137.
56. Lorenzo HK, Susin SA. Mitochondrial effectors in caspase-independent cell death. FEBS Lett 2004; 557:14-20.
57. Gogvadze V, Robertson JD, Enoksson M, Zhivotovsky B, Orrenius S. Mitochondrial cytochrome c release may occur by volume-dependent mechanisms not involving permeability transition. Biochem J 2004; 378:213-217.
58. Vyssokikh M, Zorova L, Zorov D, Heimlich G, Jürgensmeier J, Schreiner D, et al. The intramitochondrial cytochrome c distribution varies correlated to the formation of a complex between VDAC and the adenine nucleotide translocase: this affects Bax-dependent cytochrome c release. Biochim Biophys Acta 2004; 1644:27-36.
59. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292:727-730.
60. Kim TH, Zhao Y, Barber MJ, Kuharsky DK, Yin XM. Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax. J Biol Chem 2000; 275: 39474-39481.
61. Shimizu S, Tsujimoto Y. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. Proc Natl Acad Sci USA 2000; 97:577-582.
62. Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998; 17:37-49.
63. Zhuang J, Dinsdale D, Cohen GM. Apoptosis, in human monocytic THP 1 cells, results in the release of cytochrome c from mitochondria prior to their ultracondensation, formation of outer membrane discontinuities and reduction in inner membrane potential. Cell Death Differ 1998; 5:953-962.
64. Gottlieb E, Armour SM, Harris MH, Thompson CB. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ 2003; 10:709-717.
65. Scorrano L, Korsmeyer SJ. Mechanisms of cytochrome c release by proapoptotic Bcl-2 family members. Biochem Biophys Res Commun 2003; 304:437-444.
66. Machida K, Hayashi Y, Osada H. A novel adenine nucleotide translocase inhibitor, MT-21, induces cytochrome c release by a mitochondrial permeability transition-independent mechanism. J Biol Chem 2002; 277:31243-31248.
67. Belzacq AS, El Hamel C, Vieira HL, Cohen I, Haouzi D, Metivier D, et al. Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. Oncogene 2001; 20:7579-7587.
68. Bauer MK, Schubert A, Rocks O, Grimm S. Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol 1999; 147:1493-1502.
69. Halestrap A. A pore way to die. Nature 2005; 434:578-579.
70. Zoratti M, Szabò I, De Marchi U. Mitochondrial permeability transitions: how many doors to the house? Biochim Biophys Acta 2005; 1706: 40-52.
71. 2+: a control point for apoptosis. Science 2003; 300:135-139.
72. Hajnoczky G, Davies E, Madesh M. Calcium signaling and apoptosis. Biochem Biophys Res Commun 2003; 304:445-454.
73. Henry TR, Wallace KB. Differential mechanisms of induction of the mitochondrial permeability transition by quinones of varying chemical reactivities. Toxicol Appl Pharmacol 1995; 134:195-203.
74. Kristián T, Gertsch J, Bates TE, Siesjö BK. Characteristics of the calcium-triggered mitochondrial permeability transition in nonsynaptic brain mitochondria: effect of cyclosporin A and ubiquinone 0. J Neurochem 2000; 74:1999-2009.
75. Ichas F, Mazat JP. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim Biophys Acta 1998; 1366:33-50.
76. Dodoni G, Canton M, Petronilli V, Bernardi P, Di Lisa F. Induction of the mitochondrial permeability transition by the DNA alkylating agent N-methyl-N′-nitro-N-nitrosoguanidine. Sorting cause and consequence of mitochondrial dysfunction. Biochim Biophys Acta 2004; 1658:58-63.